Related Experiment Videos

Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways

H Luo1, P Rose, D Barber

  • 1Developmental Genetics Group, Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

New mutations in the Hop Janus kinase (Jak) pathway in Drosophila cause developmental defects by hyperactivating signaling. This research highlights Drosophila as a model for studying mammalian Jak-Stat pathways and hematopoiesis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • Janus kinases (Jak) are crucial for cytokine signaling.
  • The hop(Tum-l) mutation in Drosophila causes developmental defects, suggesting a hyperactive kinase.

Purpose of the Study:

  • To investigate a new dominant mutation, hop(T42), in the Drosophila Hop Jak kinase.
  • To elucidate the mechanism of Hop Jak kinase hyperactivation and its effect on the D-Stat pathway.

Main Methods:

  • Characterization of the hop(T42) mutation (E695K) in the JH2 domain.
  • Overexpression of mutant Hop proteins in Drosophila cells.
  • Assessing D-Stat phosphorylation and activation.
  • Phenotypic rescue experiments by reducing D-Stat activity.
  • Generating analogous mutations in murine Jak2 and testing in COS cells.

Main Results:

  • The hop(T42) mutation causes more extreme developmental abnormalities than hop(Tum-l).
  • Both hop(Tum-l) and hop(T42) lead to hyperphosphorylation and hyperactivation of D-Stat.
  • Reduced D-Stat activity partially rescued the hop(T42) phenotype.
  • The analogous E695K mutation in murine Jak2 increased autophosphorylation and Stat5 activation.

Conclusions:

  • Mutant Hop proteins exhibit increased tyrosine kinase activity, hyperactivating the Hop-D-Stat pathway.
  • Drosophila serves as a relevant model for dissecting mammalian Jak-Stat pathway function.
  • A model for the Hop-D-Stat pathway's role in Drosophila hematopoiesis is proposed.

Related Concept Videos